Literature DB >> 29920946

Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method.

A-S Dincq1, S Lessire1, G Pirard1, R Siriez2, M Guldenpfennig3, J Baudar3, J Favresse3, J Douxfils2,4, F Mullier3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29920946     DOI： 10.1111/ijlh.12870

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN： 1751-5521            Impact factor:   2.877


× No keyword cloud information.
  4 in total

1.  Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers.

Authors:  Ramin Artang; Maren Anderson; Jorn D Nielsen
Journal:  Res Pract Thromb Haemost       Date:  2019-05-12

2.  International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study.

Authors:  Fanny Ofek; Dana Barchel; Nofar Perets; Tomer Ziv-Baran; Ahmad Mahajna; Talia Filipovich-Rimon; Osnat Garach-Jehoshua; Maya Berlin; Matitiahu Berkovitch
Journal:  Front Pharmacol       Date:  2019-10-08       Impact factor: 5.810

3.  Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban.

Authors:  Florian Härtig; Ingvild Birschmann; Andreas Peter; Sebastian Hörber; Matthias Ebner; Matthias Sonnleitner; Charlotte Spencer; Paula Bombach; Maria-Ioanna Stefanou; Johannes Tünnerhoff; Annerose Mengel; Joachim Kuhn; Ulf Ziemann; Sven Poli
Journal:  Neurol Res Pract       Date:  2021-03-01

4.  Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study.

Authors:  Anne-Laure Sennesael; Anne-Sophie Larock; Jonathan Douxfils; Laure Elens; Gabriel Stillemans; Martin Wiesen; Max Taubert; Jean-Michel Dogné; Anne Spinewine; François Mullier
Journal:  Thromb J       Date:  2018-11-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.